Cookie Consent by

Conference Sessions

During the educational activities you will be able to asses current knowledge presented by world’s leading scientists who discuss the latest developments in kidney research, spanning from current findings of interest to the renal community, to basic science, clinical nephrology, acute and chronic kidney disease, hemodialysis and peritoneal dialysis management, kidney transplantation, and epidemiology.

Attending the educational activities will enhance your professional and personal development. It will allow you to integrate and relate clinical practice with research and innovation, which will lead you to improved patient outcomes and quality of life.

Thursday, September 22, 2022


Molecular insights and novel approaches towards individualized AVF care

The aim of the session is to summarize the current understanding of the molecular biology of arteriovenous fistula (AVF). It intends to encourage vascular access teams, care providers, and scientists, to explore new molecular tools for assessing the suitability of patients for AVF as vascular access for maintenance hemodialysis (HD). This session also highlights the most recent discoveries and may serve as a guide to explore biomarkers and technologies for the assessment of kidney disease patients choosing to start kidney replacement therapy.  

7:00 AM - 7:45 AM
  • Nadja Grobe, PhD
    Renal Research Institute, New York, NY

Genomic biorepositories and kidney research

The talk will focus on the recent progress in genetics and genomics research, which now enable introduction of genetic testing in kidney care. The combination of genetic and electronic health data can advance research and provide you opportunities for delivering more tailored care for patients with kidney diseases.

7:45 AM - 8:05 AM
  • Ali Gharavi, MD
    Columbia University, New York, NY

Vascular calcification: role oxidative stress and inflammation

Vascular calcification is a common complication in CKD. So far, studies aimed at unraveling the pathophysiology have focused on the role of a disturbed mineral metabolism. CKD is als a state of microinflammation. Mointing evidence points to inflammation and oxidative stress as underappreciated catalysators of vascular calcification.  

8:05 AM - 8:15 AM
  • Pieter Evenepoel, MD, PhD
    Katholieke University, Leuven, Belgium

AI in Kidney Disease

This session will start with an overview of artificial intelligence (AI), including examples of AI in everyday life, different learning types, and model performance measures.  Then you will review examples of how AI has been used in nephrology.  This includes a discussion on using deep learning to predict acute kidney injury at various time points, random forest to predict the progression of diabetic kidney disease, and deep learning to determine left ventricular ejection fraction using electrocardiograms.  The talk will end with a brief overview of current barriers to implementing AI into nephrology clinical care and discuss efforts to break these barriers.  

8:15 AM - 8:45 AM
  • Lili Chan, MD, MSCR
    Icahn School of Medicine at Mount Sinai, New York, NY

Long-term PD-related peritoneal membrane changes using physiological solutions in a child

This session reviews the differences in peritoneal dialysis-related issues among pediatric PD patients including developmental changes of the peritoneum, the high prevalence of high transporters on PET, the impact on dialysis prescription, pH trauma caused by conventional PD solutions and long-term effects of PD using either conventional and physiologic PD solutions in children and adolescents. The session features unseen peritoneal biopsies after 6 years of PD using physiologic solutions.

8:45 AM - 9:05 AM
  • Guido Filler, MD, PhD, FRCPC
    Western University, London, ON Canada



9:05 AM - 9:30 AM

Roundtable Discussion

The goal of this session is a roundtable discussion with Drs. Amaka Eneanya, Maria Ferris, Jeroen Kooman, and Peter Kotanko and will talk about the novel and emerging therapies, racial disparity, and other issues facing nephrologists, which all could be topics for the 25th anniversary of the RRI Conference.

9:30 AM - 10:15 AM
  • Amaka Eneanya, MD, MPH, FASN
    Fresenius Medical Care, Philadelphia, PA
  • Maria E. Ferris, MD, MPH, PhD
    UNC Chapel Hill, Chapel Hill, NC
  • Jeroen Kooman, PhD
    Maastricht University Medical Centre, Maastricht, The Netherlands
  • Peter Kotanko, MD, FASN
    Renal Research Institute, New York, NY

Exercise in dialysis - ready for prime time?

Despite decades of research demonstrating that exercise can improve the health and quality of life of hemodialysis (HD) patients, the implementation of exercise programs in dialysis clinics today is scarce, and physical inactivity and dysfunction remain a hallmark of the disease. As a result, groups worldwide are beginning to rethink how physical activity and exercise is prescribed in HD patients, as well as how to evaluate the efficacy of these programs. This presentation will critically assess data from major clinical trials on exercise in HD patients, discuss novel approaches that groups worldwide are using to improve the efficacy of exercise interventions, and discuss policy prescriptions that are needed to improve implementation.  

10:15 AM - 10:45 AM
  • Kenneth Wilund, PhD
    University of Illinois at Urbana-Champaign, Urbana, IL

Wearables: potential applications in patients with kidney disease

Wearable sensor devices have been used in various chronic diseases like heart failure. For chronic kidney disease, the experience is more limited. Wearable sensor devices may identify undetected signals by conventional means, which may be relevant for the treatment and may also play a role in the self-management of patients on dialysis. In this talk, the potential and challenges of wearable sensors in the integrated care of patients on dialysis will be discussed after a short discussion on the technical principles.  

10:45 AM - 11:05 AM
  • Jereon Kooman, PhD
    Maastricht Universtiy Medical Centre, Maastricht, The Netherlands

Conference wrap up


11:05 AM - 11:10 AM
  • Peter Kotanko, MD, FASN
    Renal Research Institute, New York, NY